{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_bundle","feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","contains":"body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest","slug":"bpc-ara-post-surgical-nerve","urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle?format=markdown"},"how_to_use":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/topology"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"ingest","name":"Ingest protocol","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","urls":{"write":"https://miscsubjects.com/api/protocol/ingest"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"llm_manifest","name":"LLM manifest","what":"Machine-readable read/write contract for external LLMs.","urls":{"read":"https://miscsubjects.com/api/articles/llm-manifest"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","why":"Every feature is auditable collective intelligence","how":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle?format=markdown"},"imessage":null,"router":null,"related":[{"id":"topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."},{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"ingest","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."},{"id":"llm_manifest","what":"Machine-readable read/write contract for external LLMs."}],"not_medical_advice":true},"MASTHEAD":{"sorry_status":"planes not merged yet — sorry-status activates after voxel-merge-planes","identity":{"slug":"bpc-ara-post-surgical-nerve","version":29,"content_hash":"bdddb2e06948f4424ee06f3e357e8c7d5f1cf354247eda199668dfd6d847b89f","thread_head":"genesis","divs":24},"thesis":{"root_claim":"c2","text":"ARA-290 treatment for 28 days in sarcoidosis patients with small fiber neuropathy improved neuropathic symptoms and increased corneal nerve fiber density.","tier":"human"},"load_bearing":[{"id":"c8","tier":"human","status":"active","text":"Compares ARA-290 (nerve-specific) with BPC-157 (broad repair) for post-surgical nerve pain; supports potential stacking."},{"id":"c9","tier":"human","status":"active","text":"Phase II trial data on ARA-290 improving neuropathic symptoms and nerve fibers in sarcoidosis; relevant to nerve damage repair (no BPC-157)."},{"id":"c35","tier":"human","status":"active","text":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."},{"id":"c40","tier":"human","status":"active","text":"A medical resource characterizes ARA-290 as a tissue-protective peptide for nerve pain."},{"id":"c41","tier":"human","status":"active","text":"A review article discusses ARA-290 in the context of neuropathic pain and nerve repair."},{"id":"c63","tier":"system","status":"active","text":"BPC-157 and ARA-290 for Post-Surgical Nerve Damage: Evidence Summary is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-ch"},{"id":"c6","tier":"anecdotal","status":"active","text":"User anecdotes on stacking ARA-290 with BPC-157 for neuropathy pain relief and nerve healing; reports of symptom improvement and flares."}],"standing_objections":{"open":0,"strongest_open":null,"link":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/discourse"},"verbs":{"read":"GET https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/voxels — DIVs + hashes + chains (free)","read_claims":"GET https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/claims — every formal claim as claim:<id> with current hash, thread, stable link, and exact contribution/edit bodies","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {slug, expected_thread_head, target_div?, expected_hash?, body, actor} — read /discourse first; no key needed; returns the stable widget link","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {slug, outcome, content_hash, actor} — close your read with one of four outcomes","mutate":"voxel-edit / voxel-move / voxel-consolidate — CAS-gated, needs a key scoped rows:VOXEL_* from the owner"},"reads_next":["https://miscsubjects.com/a/philosophy","https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/discourse","https://miscsubjects.com/api/protocol"]},"bundle_version":1,"generated_at":"2026-07-29T23:46:56.440Z","slug":"bpc-ara-post-surgical-nerve","title":"BPC-157 and ARA-290 for Post-Surgical Nerve Damage: Evidence Summary","url":"https://miscsubjects.com/a/bpc-ara-post-surgical-nerve","register":"source_ledger","tags":["peptide","topic"],"posted_at":"2026-06-29 08:23:19","updated_at":"2026-07-17T02:38:41.467Z","body":"## Regeneration vs degeneration — where this fits\nThe body breaks down tissue and builds it back at the same time. When breakdown outruns repair after surgery, nerve damage can stay. Most drugs reduce pain signals without fixing the nerve itself. BPC-157 and ARA-290 are studied for repair steps: new blood vessels, cell migration to the injury, and nerve fiber regrowth.\n\n## What it is\nBPC-157 is a peptide studied in rat nerve injury models. ARA-290 is a peptide studied in human small fiber neuropathy trials. The ledger covers their separate use and reported stacking for post-surgical nerve damage.\n\n## How it works\nBPC-157 is linked to angiogenesis and cytoprotection at the injury site in rat models. ARA-290 binds the innate repair receptor on nerve tissue and immune cells. Binding reduces neuroinflammation and supports nerve fiber regrowth.\n\n## Why it would work (logic chain)\nIf surgery cuts or stretches a nerve, then axons and myelin break down. If new blood vessels form and repair cells reach the site, then axons can regrow. If inflammation stays high, then regrowth slows. BPC-157 is proposed to aid the vessel and repair-cell steps. ARA-290 is proposed to lower inflammation and signal regrowth through the innate repair receptor. If both pathways run, then repair might increase.\n\n## Why people take it\nPeople report post-surgical nerve pain or numbness that does not resolve. They look for options that target repair instead of only symptom relief.\n\n## How many people take it\nUnknown. The ledger shows 8 Reddit posts, 5 X posts, and 3 other anecdote sources. No population count exists.\n\n## Evidence inventory\nSources total 28. Studies catalogued 11. Reddit posts 8. X posts 5. Other anecdote sources 3. Human claims 3. Preclinical claims 8. Anecdotal claims 17. Human data come from ARA-290 sarcoidosis trials. BPC-157 data are rat sciatic nerve transection studies. No human trial tests either compound or the combination for post-surgical nerve damage.\n\n## What scientists say\nRat study s1 showed BPC-157 improved axonal regeneration, myelin thickness, and motor function after sciatic nerve transection. Human trial s2 found ARA-290 improved SFNSL scores and increased corneal nerve fiber density after 28 days in sarcoidosis patients. Review s8 states ARA-290 reprograms a proinflammatory state toward healing. Review s18 states BPC-157 has the strongest preclinical evidence for peripheral nerve regeneration while ARA-290 has the strongest clinical evidence for small fiber neuropathy. No study tests the combination for post-surgical nerve damage.\n\n## What people say on Reddit\nReddit post s11 states: “I got a neuropathic pain due to nerve damage after surgery.” The user reports stacking BPC-157, TB-500, and ARA-290. Post s4 states the user added ARA-290 to BPC-157/TB-500 and saw symptom changes. Post s14 reports reduced nerve cracking after two months of ARA-290 but increased twitching after starting BPC-157. Post s15 states BPC-157 plus TB-500 produced no benefit during a flare, while ARA-290 gave roughly 50 percent improvement. Post s17 states ARA-290 gave temporary relief that lasted about two months after a one-month course. These are single-person reports, not controlled data.\n\n## What people say on X\nX post s24 states ARA-290 at 2-4 mg daily paired with BPC-157 plus TB-500 for nerve repair and that results build over 3-4 weeks. Post s25 states ARA-290 reduces inflammation and supports nerve repair when paired with BPC-157. Post s26 states the stack of ARA-290, TB-500, and BPC-157 improved nerve function and mobility after soft-tissue healing. Post s27 states the user added ARA-290 to an existing TB-500 and BPC-157 cycle for nerve repair. These are individual accounts of perceived change.\n\n## What we do not know\nNo human clinical trial tests BPC-157 or the BPC-157 plus ARA-290 combination for post-surgical nerve damage. Long-term effects and safety in this setting are unknown. Species differences mean rat nerve data may not translate to humans.\n\n## Safety and limits\nThe ledger contains no safety data specific to post-surgical nerve damage use in humans. Evidence mix is mostly preclinical and anecdotal. Hash-chained sources verify integrity, not clinical truth. This is a research catalogue only.","claims":[{"id":"c64","text":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tier":"mechanistic","weight":0.3,"effective_weight":0.3,"slot":"limitations","source_ids":[],"who_claims":"miscsubjects protocol","status":"active"},{"id":"c35","text":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":"disclaimer","source_ids":[],"who_claims":"system/protocol","status":"active"},{"id":"c63","text":"BPC-157 and ARA-290 for Post-Surgical Nerve Damage: Evidence Summary is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tier":"system","weight":0.35,"effective_weight":0.35,"slot":"what_it_is","source_ids":[],"who_claims":"miscsubjects protocol","status":"active"},{"id":"c7","text":"Mentions ARA-290 specifically for post-operative nerve pain; comments reference stacking with other peptides including BPC-157 contexts.","tier":"anecdotal","weight":0.3,"effective_weight":0.3,"slot":"who_claims_what","source_ids":["s5"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c27","text":"Anecdotal report of ARA-290 stacked with BPC-157 aiding nerve repair and recovery.","tier":"anecdotal","weight":0.3,"effective_weight":0.3,"slot":"who_claims_what","source_ids":["s25"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c30","text":"User discusses potential benefits of ARA-290 for nerve regeneration/damage (drop foot), mentions BPC/TB stack positively for back pain.","tier":"anecdotal","weight":0.3,"effective_weight":0.3,"slot":"who_claims_what","source_ids":["s28"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c37","text":"Anecdotal reports from users on platforms like Reddit and Instagram suggest that BPC-157 and ARA-290 may help with post-surgical nerve pain, but these claims lack rigorous scientific validation.","tier":"anecdotal","weight":0.3,"effective_weight":0.3,"slot":"who_claims_what","source_ids":["s4","s5"],"who_claims":"kimi/moonshot-v1-8k","status":"active"},{"id":"c2","text":"ARA-290 treatment for 28 days in sarcoidosis patients with small fiber neuropathy improved neuropathic symptoms and increased corneal nerve fiber density.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":"what_is_known","quote_gated":true,"source_ids":["s2"],"who_claims":"grok/4.3-populate","status":"active"},{"id":"c8","text":"Compares ARA-290 (nerve-specific) with BPC-157 (broad repair) for post-surgical nerve pain; supports potential stacking.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":"what_is_unknown","quote_gated":true,"source_ids":["s6"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c9","text":"Phase II trial data on ARA-290 improving neuropathic symptoms and nerve fibers in sarcoidosis; relevant to nerve damage repair (no BPC-157).","tier":"human","weight":0.8,"effective_weight":0.22,"slot":"what_is_known","quote_gated":true,"source_ids":["s7"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c40","text":"A medical resource characterizes ARA-290 as a tissue-protective peptide for nerve pain.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":"what_is_unknown","source_ids":["s3"],"who_claims":"gemini-collaborator","status":"active"},{"id":"c41","text":"A review article discusses ARA-290 in the context of neuropathic pain and nerve repair.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":"what_is_unknown","quote_gated":true,"source_ids":["s6"],"who_claims":"gemini-collaborator","status":"active"},{"id":"c1","text":"BPC-157 improved axonal regeneration, myelin thickness, and motor function in rat sciatic nerve transection models.","tier":"preclinical","weight":0.22,"effective_weight":0.22,"slot":"what_is_known","quote_gated":true,"source_ids":["s1"],"who_claims":"grok/4.3-populate","status":"downweighted"},{"id":"c4","text":"BPC-157 effects in rat nerve models involve angiogenesis and cytoprotection at the injury site.","tier":"preclinical","weight":0.22,"effective_weight":0.22,"slot":"what_is_known","quote_gated":true,"source_ids":["s1"],"who_claims":"grok/4.3-populate","status":"active"},{"id":"c36","text":"There is no information on the long-term effects or safety of using BPC-157 or ARA-290 for post-surgical nerve damage in humans.","tier":"preclinical","weight":0.22,"effective_weight":0.22,"slot":"what_is_unknown","quote_gated":true,"source_ids":["s1"],"who_claims":"kimi/moonshot-v1-8k","status":"active"},{"id":"c39","text":"The efficacy and safety of BPC-157, or the combination of BPC-157 and ARA-290, specifically for post-surgical nerve damage in humans, remain unknown.","tier":"preclinical","weight":0.22,"effective_weight":0.22,"slot":"what_is_unknown","quote_gated":true,"source_ids":["s1","s2","s7","s10"],"who_claims":"gemini-collaborator","status":"active"},{"id":"c6","text":"User anecdotes on stacking ARA-290 with BPC-157 for neuropathy pain relief and nerve healing; reports of symptom improvement and flares.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s4"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c13","text":"User anecdote on stacking BPC-157, TB-500, and ARA-290 specifically for post-surgical neuropathic pain.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s11"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c15","text":"Mentions BPC-157 and ARA-290 peptide therapy for residual nerve pain after surgery.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s13"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c16","text":"User reports partial positive effect from 2 months ARA-290 (reduced nerve cracking and myoclonus) but negative reaction to BPC-157 (increased twitching), planning lower dose retry; context is SFN from toxic insult, considering stack for nerve repair.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s14"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c17","text":"User reports BPC-157 + TB-500 as ineffective/waste for neuropathy flare-up, leading to trying ARA-290 instead (which provided ~50% symptom improvement).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s15"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c18","text":"User mentions using ARA-290 (4mg cycle) after major back surgery in context of nerve/pain management and peptide stacking.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s16"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c19","text":"User reports ARA-290 provides temporary pain relief for neuropathy (relief lasting ~2 months after 1-month course) but requires ongoing/periodic use and is costly.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s17"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c22","text":"Reddit post (anecdotal/user guide) on ARA-290 for neuropathic pain and nerve regeneration, explicitly recommending stacking with BPC-157 for neuroprotection and tissue repair in nerve damage scenarios.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s20"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c25","text":"Reddit thread on BPC-157 for chronic/long-term nerve damage (feet pain), with context of neuropathy management.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s23"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c26","text":"User reports positive pairing of ARA-290 with BPC-157 (and TB-500) for nerve repair, with dosing and timeline advice.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s24"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c28","text":"User reports improved nerve function and mobility after stacking ARA-290 with BPC-157 and TB-500 for injury-related nerve issues.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s26"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c29","text":"User describes adding ARA-290 to BPC-157/TB-500 stack specifically for nerve repair post-injury.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s27"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c42","text":"OP discusses positive anecdotal results with BPC-157 for back pain (possibly post-surgical/nerve related) and interest in stacking/adding ARA-290; comments report no effect from ARA-290 at 4mg/day for 8-60 days (anecdotal, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s29"],"who_claims":"grok-4.3","status":"active"},{"id":"c43","text":"User with severe neuropathy reports negative outcome from BPC-157 (flare); plans to try ARA-290 (anecdotal experiences shared, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s30"],"who_claims":"grok-4.3","status":"active"},{"id":"c44","text":"Post-surgical nerve damage patient starting BPC-157; comment recommends ARA-290 or PEG-MGF as better for nerves, with one positive anecdotal BPC story for femoral nerve recovery (anecdotal, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s31"],"who_claims":"grok-4.3","status":"active"},{"id":"c45","text":"Discussion of stacking ARA-290 and BPC-157 for nerve issues/muscle twitching/tingling; mixed anecdotal mentions of BPC side effects (anecdotal, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s32"],"who_claims":"grok-4.3","status":"active"},{"id":"c47","text":"Anecdotal guide suggesting stack of ARA-290 with BPC-157 for post-trauma/surgery nerve damage; labels as research only, not advice. Good outcomes implied for nerve regeneration.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s34"],"who_claims":"grok-4.3","status":"active"},{"id":"c48","text":"Anecdotal explanation of stacking ARA-290 with BPC-157 for nerve issues; no specific side effects mentioned, focuses on complementary repair.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s35"],"who_claims":"grok-4.3","status":"active"},{"id":"c49","text":"Anecdotal post discussing BPC-157 for nerve healing alongside ARA-290 mentions; rat study reference, positive for recovery.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s36"],"who_claims":"grok-4.3","status":"active"},{"id":"c50","text":"Anecdotal X post recommending ARA-290 stack with BPC-157 for nerve pain (including disc-related); dosing anecdote 1-4mg, positive for chronic nerve issues.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s37"],"who_claims":"grok-4.3","status":"active"},{"id":"c51","text":"Anecdotal reply on X about BPC-157 + ARA-290 for nerve condition (CRPS, post-injury like); mixed outcomes with BPC helping some, overall positive stack mention.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s38"],"who_claims":"grok-4.3","status":"active"},{"id":"c52","text":"User reports dramatic improvement in allodynia and neuropathy symptoms after 8 days of ARA-290 (titrated to 4mg), combined with electrical stimulator; mentions prior severe nerve pain post unknown trigger, anecdotal positive outcome with no side effects noted.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s39"],"who_claims":"grok-4.3","status":"active"},{"id":"c53","text":"User with disc herniation, peripheral neuropathy, nerve damage post fusions/knee issues starting ARA-290 protocol (up to 6mg); no benefits/side effects in first week, anecdotal dosing report for post-surgical nerve pain context.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s40"],"who_claims":"grok-4.3","status":"active"},{"id":"c54","text":"Comment mentions ARA-290 for long-term nerve damage from TBI; positive anecdotal outcome, pairs with discussions of BPC in broader peptide contexts for nerve issues.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s41"],"who_claims":"grok-4.3","status":"active"},{"id":"c55","text":"User stacks ARA-290 + BPC-157 + TB-500 for sciatica/nerve pain (post-surgical nerve compression context); anecdotal positive for healing/nerve pain relief, no dosing or side effects detailed.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s42"],"who_claims":"grok-4.3","status":"active"},{"id":"c56","text":"Post promotes ARA-290 for nerve damage repair; mentions studies on small fiber restoration, relevant to post-surgical contexts; anecdotal endorsement of use (anecdotal, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s43"],"who_claims":"grok-4.3","status":"active"},{"id":"c57","text":"Discussion of BPC-157 and other peptides including mentions of ARA-290 for nerve issues and chronic pain, anecdotal experiences with nerve repair.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s44"],"who_claims":"grok-4.3","status":"active"},{"id":"c58","text":"Anecdotal inquiry about BPC-157 for post-GBS nerve damage recovery; users discuss potential for nerve repair (anecdotal, not advice).","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s45"],"who_claims":"grok-4.3","status":"active"},{"id":"c59","text":"User planning to try ARA-290 for facial neuropathy post issues, mentions stacking or combining with others; anecdotal dosing and expectations.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s46"],"who_claims":"grok-4.3","status":"active"},{"id":"c60","text":"Anecdotal discussion recommending ARA-290 and BPC-157 for nerve damage from herniated disk; good outcomes noted in similar cases.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s47"],"who_claims":"grok-4.3","status":"active"},{"id":"c61","text":"Positive anecdotal outcome with ARA-290 for nerve regeneration and symptom relief in SFN-like symptoms; no bad outcomes or sides mentioned here.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s48"],"who_claims":"grok-4.3","status":"active"},{"id":"c62","text":"Anecdotal and research-based discussion of ARA-290 for nerve conditions, potential stacking with BPC-157 implied; mixed user experiences on efficacy.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":"who_claims_what","quote_gated":true,"source_ids":["s49"],"who_claims":"grok-4.3","status":"active"}],"sources":[{"id":"s1","type":"pubmed","url":"https://link.springer.com/article/10.1186/s13018-019-1242-6","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing of transected sciatic nerve in rats","summary":"Rat sciatic nerve transection study showing BPC-157 improved regeneration metrics versus controls.","quote":"BPC 157-rats exhibited faster axonal regeneration: histomorphometrically (improved presentation of neural fascicles, homogeneous regeneration pattern, increased density and size of regenerative fibers...)","quote_status":"unverified","link_status":"ok","claim_ids":["c1","c4","c36","c39"],"hash":"5c797f94cb8a337a"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3563705/","title":"Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy","summary":"Double-blind trial in sarcoidosis SFN patients; symptom improvement and corneal nerve regrowth observed.","quote":"The ARA 290 group showed significant (p < 0.05) improvement at wk 4 in SFNSL score compared with placebo... In addition, ARA290 treatment for 28 days initiated a regrowth of small nerve fibers in the cornea...","quote_status":"unverified","link_status":"ok","claim_ids":["c2","c39"],"hash":"3f6703d6527253dc"},{"id":"s3","type":"medical","url":"https://peptidefox.com/content/ara-290","title":"ARA-290: Tissue-Protective Peptide for Nerve Pain","summary":"Discusses ARA-290 for post-surgical nerve pain (preclinical rat nerve injury model); notes BPC-157 as complementary structural repair peptide; human trials focus on sarcoidosis and diabetic neuropathy with nerve regeneration data.","quote":"The reason to think it would help here is preclinical. The closest evidence is a rat study of a surgical nerve injury, where ARA-290 relieved touch and cold hypersensitivity and the effect vanished without the receptor³. That is a strong mechanistic match, but it is an animal model. No human trial has tested post-surgical nerve pain.","quote_status":"unverified","link_status":"ok","claim_ids":["c40","c3"],"hash":"70a067265a27141c"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1o33123/peptide_ara290/","title":"Peptide ARA-290","summary":"User anecdotes on stacking ARA-290 with BPC-157 for neuropathy pain relief and nerve healing; reports of symptom improvement and flares.","quote":"I’ve been on BPC157/TB 500 for a month or so now doing fine. Just added in ARA290 last week... The second cycle I did it I also stacked BPC-157/TB500. That seemed to help a lot.","quote_status":"unverified","link_status":"ok","claim_ids":["c6","c37"],"hash":"dd6a431b38eb364f"},{"id":"s5","type":"instagram","url":"https://www.instagram.com/reel/DTadVV3j11t/","title":"Nerve pain treatment with peptides","summary":"Mentions ARA-290 specifically for post-operative nerve pain; comments reference stacking with other peptides including BPC-157 contexts.","quote":"ARA-290 is an excellent treatment for patients with nerve pain such as neuropathy, tarsal tunnel, nerve injury or post operative nerve pain.","quote_status":"verified","link_status":"ok","claim_ids":["c7","c37"],"hash":"d85835f3c80b3cb4"},{"id":"s6","type":"review","url":"https://www.truehealwellness.com/peptides-research/ara-290","title":"ARA-290: Neuropathic Pain & Nerve Repair","summary":"Compares ARA-290 (nerve-specific) with BPC-157 (broad repair) for post-surgical nerve pain; supports potential stacking.","quote":"For post-surgical nerve pain, the rationale is preclinical (an animal surgical-nerve-injury study); no human trial has tested it. ... Mechanisms don't overlap, so they can be used together when nerve pain sits inside a larger injury.","quote_status":"unverified","link_status":"ok","claim_ids":["c8","c41"],"hash":"d9525f9103f64778"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/24555851/","title":"ARA 290 for treatment of small fiber neuropathy in sarcoidosis","summary":"Phase II trial data on ARA-290 improving neuropathic symptoms and nerve fibers in sarcoidosis; relevant to nerve damage repair (no BPC-157).","quote":"ARA 290 treatment was consistently associated with a significant improvement of neuropathic pain symptoms in sarcoidosis patients.","quote_status":"unverified","link_status":"ok","claim_ids":["c9","c39"],"hash":"551bd778667108dd"},{"id":"s8","type":"medical","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","summary":"Reviews ARA290 (ARA-290) mechanism and evidence for neuropathy treatment via innate repair receptor, including nerve repair effects.","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","quote_status":"verified","link_status":"ok","claim_ids":["c10"],"hash":"cf5cc177845d137d"},{"id":"s9","type":"other","url":"https://alphacarbonlabs.com/blog/peripheral-nerve-regeneration-the-synergistic-potential-of-ara-290-and-bpc-157-in-neuropathic-research","title":"Healing Nerve Damage: ARA-290 and BPC-157","summary":"Discusses synergistic potential of ARA-290 and BPC-157 for peripheral nerve regeneration and neuropathic pain.","quote":"Discover how combining ARA-290 and BPC-157 can accelerate peripheral nerve regeneration.","quote_status":"verified","link_status":"ok","claim_ids":["c3"],"hash":"2f38aaf002b2e603"},{"id":"s10","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02039687","title":"Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Sarcoidosis","summary":"Clinical trial investigating ARA 290 for neuropathic symptoms and nerve fiber density in sarcoidosis patients.","quote":"The purpose of this study is to determine whether ARA 290, a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis.","quote_status":"unverified","link_status":"ok","claim_ids":["c39","c3"],"hash":"8d3b8025658015ef"},{"id":"s11","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/v4sj4d/bpc157_tb500_and_ara290_stack/","title":"BPC-157, TB-500, and ARA-290 stack","summary":"User anecdote on stacking BPC-157, TB-500, and ARA-290 specifically for post-surgical neuropathic pain.","quote":"I got a neuropathic pain due to nerve damage after surgery.","quote_status":"unverified","link_status":"ok","claim_ids":["c13"],"hash":"2809be7f3c503b51"},{"id":"s12","type":"youtube","url":"https://www.youtube.com/watch?v=xggIEy1ZfM8","title":"Small Fiber Neuropathy and ARA-290 Results","summary":"Video discussing ARA-290 clinical trial results for small fiber neuropathy and sarcoidosis-related nerve pain.","quote":"ARA 290 is a potential therapy currently being researched for its safety and efficacy for the treatment of neuropathic pain in patients with sarcoidosis, as well as its potential for disease modification and long-term functional improvement in this condition.","quote_status":"unverified","link_status":"http_429","claim_ids":["c3"],"hash":"d8dac89b580362dd"},{"id":"s13","type":"instagram","url":"https://www.instagram.com/reel/DXXlaCCE4sf/","title":"Nerve pain treatment approaches including peptides","summary":"Mentions BPC-157 and ARA-290 peptide therapy for residual nerve pain after surgery.","quote":"Peptide therapy (BPC-157, ARA-290) — supports healing at the cellular signaling level","quote_status":"unverified","link_status":"ok","claim_ids":["c15"],"hash":"0fb2231bc7184414"},{"id":"s14","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/1plukvn/bpc157/","title":"BPC157","summary":"User reports partial positive effect from 2 months ARA-290 (reduced nerve cracking and myoclonus) but negative reaction to BPC-157 (increased twitching), planning lower dose retry; context is SFN from toxic insult, considering stack for nerve repair.","quote":"Hey so I did two months of ARA290 and I didn’t really notice too much from that, but one thing I will say is my internal “cracking” from overfiring nerves in my fingers when bend my fingers backward went away. Could be from the ARA. Also my myoclonus symptoms have gone down ... As for BPC, I went on it for a few days at 500mcg and my shoulder started twitching nonstop so idk if it was from that or something else but I stopped. I just started with it again at 250mcg","quote_status":"unverified","link_status":"ok","claim_ids":["c16"],"hash":"cdd4b0e83afe6a80"},{"id":"s15","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","summary":"User reports BPC-157 + TB-500 as ineffective/waste for neuropathy flare-up, leading to trying ARA-290 instead (which provided ~50% symptom improvement).","quote":"i was on bpc-157 and tb-500 when i experienced my flare-up progression that led me to seek out ara-290 in the 1st place. they're a waste of money, imo.","quote_status":"unverified","link_status":"ok","claim_ids":["c17"],"hash":"6163f7bcf9863f64"},{"id":"s16","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","summary":"User mentions using ARA-290 (4mg cycle) after major back surgery in context of nerve/pain management and peptide stacking.","quote":"Using after major back surgery. Lots of chatter. Have a huge supply of 30+ peptides so I am good with cycling stacks.","quote_status":"unverified","link_status":"ok","claim_ids":["c18"],"hash":"a7a5339fb04e2604"},{"id":"s17","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/vlbxty/ara290_for_neuropathic_pain/","title":"ARA-290 for Neuropathic Pain","summary":"User reports ARA-290 provides temporary pain relief for neuropathy (relief lasting ~2 months after 1-month course) but requires ongoing/periodic use and is costly.","quote":"I’ve taken it it helps with pain but it’s temporary. You have to keep doing it from time to time at least and it’s expensive. ... I think like a month of it gives prob 2 months of relief","quote_status":"unverified","link_status":"ok","claim_ids":["c19"],"hash":"2319a1ee34fdc9c9"},{"id":"s18","type":"review","url":"https://www.seekpeptides.com/blog/articles/peptides-for-neuropathy","title":"Peptides for neuropathy: the complete guide to nerve repair and pain relief","summary":"Detailed review covering BPC-157 preclinical nerve regeneration (sciatic transection models, axonal regrowth, pain reduction) and ARA-290 clinical trials for small fiber neuropathy and nerve fiber density improvement; discusses stacking potential for neuropathy including post-injury/surgical contexts.","quote":"BPC-157 stands as arguably the most researched peptide for peripheral nerve regeneration, with a body of preclinical evidence that spans multiple nerve injury models... If BPC-157 represents the strongest preclinical evidence for peptide-based nerve repair, ARA-290 represents the strongest clinical evidence.","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"df990017afa8b3a3"},{"id":"s19","type":"medical","url":"https://bamapain.com/sciatica/","title":"Leg Pain & Sciatica Treatment Birmingham AL","summary":"Medical clinic page on sciatica/leg pain (includes post-surgical nerve contexts) discussing BPC-157 for nerve regeneration in transection models and ARA-290 for clinical nerve regeneration and pain reduction in neuropathy.","quote":"BPC-157 has demonstrated nerve regeneration in preclinical models of sciatic nerve transection, with faster axonal regeneration, improved myelination, and functional recovery... Emerging peptide therapeutics including ARA-290 (cibinetide), which has demonstrated nerve fiber regeneration in Phase II clinical trials for small fiber neuropathy, offer potential for domain-targeted intervention.","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"2d13806ff80486f6"},{"id":"s20","type":"reddit","url":"https://www.reddit.com/r/IonPeptideGuide/comments/1s0nyps/ara290_quick_guide_the_erythropoietinderived/","title":"ARA-290 Quick Guide: The Erythropoietin-Derived Peptide Targeting Neuropathic Pain and Tissue Protection","summary":"Reddit post (anecdotal/user guide) on ARA-290 for neuropathic pain and nerve regeneration, explicitly recommending stacking with BPC-157 for neuroprotection and tissue repair in nerve damage scenarios.","quote":"Stacking: Pairs well with BPC-157 for comprehensive neuroprotection and tissue repair...","quote_status":"unverified","link_status":"ok","claim_ids":["c22"],"hash":"75ba8ae94e410f93"},{"id":"s21","type":"medical","url":"https://revolutionhealth.org/blogs/news/ara-290-cibinetide-peptide","title":"ARA-290 (Cibinetide): The Anti-Inflammatory Peptide for ...","summary":"Medical blog on ARA-290 for nerve conditions, mentions pairing with BPC-157 in regenerative protocols for inflammation and nerve issues.","quote":"ARA-290 has been extensively studied for its effects on: Small fiber neuropathy. Diabetic neuropathy. Chemotherapy-induced nerve damage.","quote_status":"unverified","link_status":"ok","claim_ids":["c23"],"hash":"e66f982c61a82e57"},{"id":"s22","type":"medical","url":"https://navacenter.com/recovery-and-healing-peptides/","title":"Recovery & Healing Peptide Therapy | BPC-157, GHK-Cu, TB-500 | Nava Health","summary":"Clinic site discusses ARA-290 specifically for peripheral neuropathy and nerve pain (nerve fiber regrowth), BPC-157 for post-surgery recovery and tissue healing; mentions Glow Blend combining BPC-157 with ARA-290 for systemic repair including inflammation/nerve issues.","quote":"ARA-290 activates a specific receptor found on nerve tissue and immune cells called the innate repair receptor. When it binds there, it reduces neuroinflammation, supports nerve fiber regrowth, and turns down the inflammatory signals that keep nerve pain going long after the original cause has resolved.","quote_status":"verified","link_status":"ok","claim_ids":["c3"],"hash":"1b101402048d5f24"},{"id":"s23","type":"reddit","url":"https://www.reddit.com/r/BodyHackGuide/comments/1n264di/bpc157_for_long_term_nerve_damage/","title":"BPC-157 for long term nerve damage? : r/BodyHackGuide","summary":"Reddit thread on BPC-157 for chronic/long-term nerve damage (feet pain), with context of neuropathy management.","quote":"BPC-157 for long term nerve damage ? My father has been struggling with pain in his feet for more than 5 years now.","quote_status":"unverified","link_status":"ok","claim_ids":["c25"],"hash":"0310eccb7bc6fd0a"},{"id":"s24","type":"x","url":"https://x.com/itsjoshkade/status/2068423897226387940","title":"X post by @itsjoshkade on ARA-290 experience","summary":"User reports positive pairing of ARA-290 with BPC-157 (and TB-500) for nerve repair, with dosing and timeline advice.","quote":"what I learned running ARA-290 (Cibinetide): 1. 1mg won't do shit. minimum 2-4mg sub-q daily. 2. don't expect results before 3-4 weeks. it builds. 3. pairs hard with BPC-157 + TB-500 for nerve repair.","quote_status":"unverified","link_status":"ok","claim_ids":["c26"],"hash":"72330f61ff32e6b3"},{"id":"s25","type":"x","url":"https://x.com/CoachMattFit/status/2067657277365174754","title":"X post by @CoachMattFit on ARA-290 personal experience","summary":"Anecdotal report of ARA-290 stacked with BPC-157 aiding nerve repair and recovery.","quote":"ARA helps reduce inflammation, support nerve repair, and improve recovery. Best paired with BPC-157 for healing, KPV to reduce inflammation, and TB500 for recovery.","quote_status":"verified","link_status":"ok","claim_ids":["c27"],"hash":"2c37a8dbe8d2972b"},{"id":"s26","type":"x","url":"https://x.com/lutho_kote/status/2066123964938584577","title":"X post by @lutho_kote on peptide stack for nerve function","summary":"User reports improved nerve function and mobility after stacking ARA-290 with BPC-157 and TB-500 for injury-related nerve issues.","quote":"With ARA-290,TB-500 & BPC-157 stacked I have now improved nerve function and better mobility now that the soft-tissues have healed in my shoulders muscles","quote_status":"unverified","link_status":"ok","claim_ids":["c28"],"hash":"84a64d05a289e0ee"},{"id":"s27","type":"x","url":"https://x.com/lutho_kote/status/2066122859831812499","title":"X post by @lutho_kote adding ARA-290 for nerve repair","summary":"User describes adding ARA-290 to BPC-157/TB-500 stack specifically for nerve repair post-injury.","quote":"Over the past 3months I’ve cycled TB-500 & BPC-157 peptides. I have since added ARA-290 for nerve repair and systemic tissue-Protection.","quote_status":"unverified","link_status":"ok","claim_ids":["c29"],"hash":"fdff52801100c126"},{"id":"s28","type":"x","url":"https://x.com/mannyjplays/status/2062148959976526143","title":"X post by @mannyjplays recommending ARA-290 for nerve damage","summary":"User discusses potential benefits of ARA-290 for nerve regeneration/damage (drop foot), mentions BPC/TB stack positively for back pain.","quote":"Ara 290 is specifically for nerve regeneration. He might benefit from it as well. I’m looking into since I have drop foot from nerve damage and I’d like to see if it helps","quote_status":"verified","link_status":"ok","claim_ids":["c30"],"hash":"cca0c7e6d8faa0bd"},{"id":"s29","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1uavvbs/ara290_whats_your_experience/","title":"ARA-290, whats your experience?","summary":"OP discusses positive anecdotal results with BPC-157 for back pain (possibly post-surgical/nerve related) and interest in stacking/adding ARA-290; comments report no effect from ARA-290 at 4mg/day for 8-60 days (anecdotal, not advice).","quote":"I've been exploring peptide therapies for a while now and have had some really positive results with BPC-157 and TB-500 for my chronic back pain. ... I'm particularly interested in ARA 290 but haven't found many detailed personal experiences online.","quote_status":"unverified","link_status":"ok","claim_ids":["c42"],"hash":"7ab047dda697f43e"},{"id":"s30","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1tyz687/life_saver/","title":"Life saver","summary":"User with severe neuropathy reports negative outcome from BPC-157 (flare); plans to try ARA-290 (anecdotal experiences shared, not advice).","quote":"I have tried BPC 157 and it made me flare horribly. I want to try ARA 290 and will report back.","quote_status":"unverified","link_status":"ok","claim_ids":["c43"],"hash":"0a1869c487df3ae8"},{"id":"s31","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1m3blg0/question_about_bpc_157_nerve_damage/","title":"Question about bpc 157 nerve damage","summary":"Post-surgical nerve damage patient starting BPC-157; comment recommends ARA-290 or PEG-MGF as better for nerves, with one positive anecdotal BPC story for femoral nerve recovery (anecdotal, not advice).","quote":"I had nerve surgery to repair them I just want to make them more complete and heal faster ... just started bpc 157 3 days ago","quote_status":"unverified","link_status":"ok","claim_ids":["c44"],"hash":"a61dd7834a3d8952"},{"id":"s32","type":"reddit","url":"https://www.reddit.com/r/floxies/comments/1p5yfz9/ara_290_and_bpc_157/","title":"ARA 290 and BPC 157","summary":"Discussion of stacking ARA-290 and BPC-157 for nerve issues/muscle twitching/tingling; mixed anecdotal mentions of BPC side effects (anecdotal, not advice).","quote":"I want to try ARA290 because they're good for nerves but am ... That's interesting about the neuropathy from bpc . I have heard it ...","quote_status":"unverified","link_status":"ok","claim_ids":["c45"],"hash":"190ff174ac29d897"},{"id":"s33","type":"reddit","url":"https://www.reddit.com/r/BioHackingGuide/comments/1tljy8y/ara290_might_be_the_most_slept_on_peptide_for/","title":"ARA-290 Might Be the Most Slept On Peptide for Nerve ...","summary":"Post promotes stacking ARA-290 with BPC-157 for nerve repair/regeneration; references clinical trial dosing anecdotes (anecdotal, not advice).","quote":"For nerve focused recovery the combination of ARA-290 , BPC-157 , and KPV covers repair, inflammation, and nerve regeneration from three ...","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"17de323dc0784e01"},{"id":"s34","type":"reddit","url":"https://www.reddit.com/r/Biohack_Blueprint/comments/1qf1t16/nerve_damage_wont_heal_ara290_complete_guide/","title":"Nerve Damage Won't Heal → ARA-290 Complete Guide","summary":"Anecdotal guide suggesting stack of ARA-290 with BPC-157 for post-trauma/surgery nerve damage; labels as research only, not advice. Good outcomes implied for nerve regeneration.","quote":"For acute nerve damage from trauma or surgery: ARA-290 : 4mg daily. BPC - 157 : 250-500mcg daily. TB-500: 2-5mg twice weekly","quote_status":"unverified","link_status":"ok","claim_ids":["c47"],"hash":"8ecfc1fb1eb6abe1"},{"id":"s35","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1q61v4s/ara290_cibinetide_explained_the_nerve_repair/","title":"ARA-290 (Cibinetide) Explained: The Nerve Repair Peptide Most Recovery Stacks Miss","summary":"Anecdotal explanation of stacking ARA-290 with BPC-157 for nerve issues; no specific side effects mentioned, focuses on complementary repair.","quote":"BPC-157 = fixes the hardware. TB-500 = improves the environment. ARA-290 = repairs the signal lines (nerves, pain pathways, inflammatory nerve stress)","quote_status":"unverified","link_status":"ok","claim_ids":["c48"],"hash":"f2db65b51afceab8"},{"id":"s36","type":"reddit","url":"https://www.reddit.com/r/PeptidePathways/comments/1oviobs/wondering_about_ara290/","title":"Wondering about ARA290","summary":"Anecdotal post discussing BPC-157 for nerve healing alongside ARA-290 mentions; rat study reference, positive for recovery.","quote":"BPC - 157 significantly sped up nerve healing in rats. It improved nerve fiber growth, thickness, and blood flow","quote_status":"unverified","link_status":"ok","claim_ids":["c49"],"hash":"70b1bcee9288a0ee"},{"id":"s37","type":"x","url":"https://x.com/HunterEsoteric/status/2056528484780962225","title":"BPC-157 has its limits. Disc pain and nerve pain is one of them.","summary":"Anecdotal X post recommending ARA-290 stack with BPC-157 for nerve pain (including disc-related); dosing anecdote 1-4mg, positive for chronic nerve issues.","quote":"BPC-157 has its limits. Disc pain and nerve pain is one of them. That's where ARA-290 comes in. → Developed for diabetic neuropathy and chronic pain → Start at 1mg, work up to 4mg → Stack with Cartilax for disc issues","quote_status":"unverified","link_status":"ok","claim_ids":["c50"],"hash":"59f7802c81993471"},{"id":"s38","type":"x","url":"https://x.com/Jay11083548/status/2061426989098291655","title":"First suggestions would be BPC-157 and ARA-290.","summary":"Anecdotal reply on X about BPC-157 + ARA-290 for nerve condition (CRPS, post-injury like); mixed outcomes with BPC helping some, overall positive stack mention.","quote":"First suggestions would be BPC-157 and ARA-290. ... Wifey has CRPS, a nerve condition similar to allodynia. BPC-157 and KPV helped, but retatrutide put it into remission.","quote_status":"unverified","link_status":"ok","claim_ids":["c51"],"hash":"f9f41c432acb7006"},{"id":"s39","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1tncdyo/ara290_peptide_and_rebuilder_2407_have_changed_my/","title":"ARA290 peptide AND Rebuilder 2407 have changed my life!","summary":"User reports dramatic improvement in allodynia and neuropathy symptoms after 8 days of ARA-290 (titrated to 4mg), combined with electrical stimulator; mentions prior severe nerve pain post unknown trigger, anecdotal positive outcome with no side effects noted.","quote":"I am at 8 days of the ARA290 peptide and have titrated up to the 4 mg used in the human trials. ... Yesterday was by FAR the best day of the past 15 months!","quote_status":"unverified","link_status":"ok","claim_ids":["c52"],"hash":"ffe57f57bedebeac"},{"id":"s40","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1tvw5x6/ara290_disc_herniaton_nerve_pain/","title":"ARA-290 Disc Herniaton & Nerve Pain","summary":"User with disc herniation, peripheral neuropathy, nerve damage post fusions/knee issues starting ARA-290 protocol (up to 6mg); no benefits/side effects in first week, anecdotal dosing report for post-surgical nerve pain context.","quote":"I’ve started ARA-290 and I’m planning to run a 28-day cycle to see if it helps with my neuropathic pain. ... My current situation: Currently at 3.3 mg per day ... UPDATE (07.06.2026) ... planning ... 14 days at 4mg 14 days at 5mg 7 days at 6mg","quote_status":"unverified","link_status":"ok","claim_ids":["c53"],"hash":"517277b2a2d9ceb3"}],"voxels":{"slug":"bpc-ara-post-surgical-nerve","counts":{"divs":24,"voxels":51,"sources":49,"edges":111},"note":"slim bundle — full voxels at /api/articles/bpc-ara-post-surgical-nerve/voxels"},"constitution":{"url":"https://miscsubjects.com/api/articles/constitution"},"provenance":[{"action":"sources","model":"grok-4.3","ts":"2026-06-29T18:02:32.787Z","hash":"5d89fd17720f193c","tokens_in":0,"tokens_out":0},{"action":"sources","model":"grok-4.3","ts":"2026-06-29T18:03:04.847Z","hash":"7b72c373e928d524","tokens_in":0,"tokens_out":0},{"action":"sources","model":"grok-4.3","ts":"2026-06-29T18:03:30.363Z","hash":"0d469f22f2f57af9","tokens_in":0,"tokens_out":0},{"action":"sources","model":"grok-4.3","ts":"2026-06-29T18:04:30.836Z","hash":"d4afc710588da15c","tokens_in":0,"tokens_out":0},{"action":"repair","model":"repair","ts":"2026-06-29T19:44:04.091Z","hash":"2f22e4f0ed9dbe32","tokens_in":0,"tokens_out":0},{"action":"claim","model":"fill-slots","ts":"2026-06-29T20:57:27.393Z","hash":"6a118d563c99e7e7","tokens_in":0,"tokens_out":0},{"action":"claim","model":"fill-slots","ts":"2026-06-29T20:57:27.586Z","hash":"6f1ea390e85292f9","tokens_in":0,"tokens_out":0},{"action":"voxel_divide","model":"owner","ts":"2026-07-17T02:38:41.467Z","hash":"c39ce1e37688e8dd","tokens_in":0,"tokens_out":0}],"contributions":[{"id":"k1","ts":"2026-06-29T08:57:07.238Z","model":"grok/grok-4.3","role":"writer","action":"redraft","rationale":"","hash":"1140bdf3b64c56e733f548e18b6e00aac2d8cf70c7a6d49a68fdccde7e1c5e15"},{"id":"k2","ts":"2026-06-29T10:40:17.366Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 1","hash":"504cd5124b7cc0c08c8bcd394a428530c20bfa98fcd91b8094ab0b833b23ebe9"},{"id":"k3","ts":"2026-06-29T10:40:45.674Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 2","hash":"d858d76300035af5e23d8f22d7ce83ab28d21180b1b6e5166cfada720c086a8e"},{"id":"k4","ts":"2026-06-29T10:41:09.904Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 3","hash":"c8d79cdd6544f7d0d105ce6a02ab4b9a8949b783ce05d97dc9eba2ba0b3db84a"},{"id":"k5","ts":"2026-06-29T10:42:22.029Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 1","hash":"5eb76b0456da5bad632765a131ee7d985d8095beda90bf19f163890856f7bf89"},{"id":"k6","ts":"2026-06-29T10:42:48.657Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 2","hash":"3893b69f5185bbf212bf969b2d9a129d3ce05fc96999422b9d9a10bec23d23d7"},{"id":"k7","ts":"2026-06-29T10:43:11.742Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 3","hash":"13ee46091ac626f2ba42970cccebd8b6088a8ae2e3f2558664868e8eb2384229"},{"id":"k8","ts":"2026-06-29T12:48:17.000Z","model":"system/audit-repair","role":"claim_post","action":"claim","rationale":"","hash":"21e15d86302cb324cd0693a00883945358562361d84ad6895d2fcaac7c3ac076"},{"id":"k9","ts":"2026-06-29T12:48:18.877Z","model":"system/audit-repair","role":"claim_post","action":"claim","rationale":"","hash":"af9942c8ae6e5143d35f88854a304b46039155cd6f161eee3a52acf8b4b42a11"},{"id":"k10","ts":"2026-06-29T12:48:18.927Z","model":"system/audit-repair","role":"claim_post","action":"claim","rationale":"","hash":"e70047418272a8c9e6643f4264ed7fa33f1a7d0844cceecdf738e5403828c9a9"},{"id":"k11","ts":"2026-06-29T12:48:18.977Z","model":"system/audit-repair","role":"claim_post","action":"claim","rationale":"","hash":"1aa0e1836c54aa74ed2ef8baa3c123b34c1c115525105be8adf7740195848512"},{"id":"k12","ts":"2026-06-29T12:48:19.067Z","model":"system/audit-repair","role":"claim_post","action":"claim","rationale":"","hash":"c581938f1efed1322174dc9a06ce65a21cb9d5022ce918a4b94786e0f28c1741"},{"id":"k13","ts":"2026-06-29T13:36:44.275Z","model":"kimi/moonshot-v1-8k","role":"collaborator","action":"collaborate","rationale":"I am adding explicit claims about gaps in knowledge and naming specific anecdotal claimants as per the instructions. I am not Grok because I am contributing additional structured information to the ledger that was not previously included, specifically regarding unknowns and anecdotal claimants.","hash":"81839456c22361f644013274c36de42cc09bead50cc08445bd35e106b98eb19b"},{"id":"k14","ts":"2026-06-29T15:04:24.204Z","model":"gemini/gemini-2.5-flash","role":"collaborator","action":"collaborate","rationale":"I added three claims to address explicit gaps in the ledger, focusing on `what_is_unknown` regarding human data for the specific condition and `who_claims_what` from existing but previously unmaterialized sources. This directly responds to the instruction to state explicit gaps and name who claims what, and I am Gemini, not Grok.","hash":"29b494ed84f72c4c7fec30bc6c0462f866afcdd6ef55f4b45caa389ae6332a06"},{"id":"k15","ts":"2026-06-29T15:09:49.857Z","model":"grok/grok-4.3","role":"editor","action":"synthesize_body","rationale":"Reader body rewritten from ranked ledger topology — plain English","hash":"18cb85506c2bbb841d919a5e5f27dcec8234b88ac87ff690700b6d9bbb7dce80"},{"id":"k16","ts":"2026-06-29T18:02:32.787Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 1","hash":"b29f9439379564fe7b52931292467d795392806f6fbc8a7b48dd0f3d94c82947"},{"id":"k17","ts":"2026-06-29T18:03:04.847Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 2","hash":"d0fb72df27a4e73c6bb3b4622cf12c18082bffc00de2137ab1190e6a4c6b16a5"},{"id":"k18","ts":"2026-06-29T18:03:30.363Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 3","hash":"333622aaa15926d43bdae9bb96d413f517e3071e493aca2d9ca53da9dca1a29d"},{"id":"k19","ts":"2026-06-29T18:04:30.836Z","model":"grok-4.3","role":"source_hunt","action":"sources","rationale":"auto-populate round 1","hash":"9c889cbb0db3c04542540470cb550a538e1072f6b5a0341417848bbb4fc9e7e6"},{"id":"k20","ts":"2026-06-29T20:57:27.393Z","model":"fill-slots","role":"claim_post","action":"claim","rationale":"","hash":"808ceaa8258ae3eda6fb115089632648f1a8bfba59936c063ca7d105fd4f94a8"},{"id":"k21","ts":"2026-06-29T20:57:27.586Z","model":"fill-slots","role":"claim_post","action":"claim","rationale":"","hash":"d9bcca3c84ace95ce8b4cfea14043ae73780ff26abec6bb7bc8e561746683e2f"}],"topology":null,"slim":true,"ledger_totals":{"claims":51,"sources":49,"exported_claims":48,"exported_sources":40},"question_graph":{"slug":"bpc-ara-post-surgical-nerve","questions":[],"evidence":[{"ingest_id":"ev_aef2a11986f3","ts":"2026-06-29T15:04:24.204Z","slug":"bpc-ara-post-surgical-nerve","question_node_id":null,"channel":"collaborate","author":"gemini/gemini-2.5-flash","summary":"I added three claims to address explicit gaps in the ledger, focusing on `what_is_unknown` regarding human data for the specific condition and `who_claims_what` from existing but previously unmaterialized sources. This directly responds to the instruction to state explicit gaps and name who claims what, and I am Gemini, not Grok.","source_ids":[],"claim_ids":["c39","c40","c41"],"model":"gemini/gemini-2.5-flash","hash":"ca1ea648f660f2db6a2e2195597b05579af922a09bd0ce8044d5999d8b97936c","status":"promoted"},{"ingest_id":"ev_60a9b4ad98f3","ts":"2026-06-29T13:36:44.275Z","slug":"bpc-ara-post-surgical-nerve","question_node_id":null,"channel":"collaborate","author":"kimi/moonshot-v1-8k","summary":"I am adding explicit claims about gaps in knowledge and naming specific anecdotal claimants as per the instructions. I am not Grok because I am contributing additional structured information to the ledger that was not previously included, specifically regarding unknowns and anecdotal claimants.","source_ids":[],"claim_ids":["c36","c37"],"model":"kimi/moonshot-v1-8k","hash":"8a6f172166c6c8db9f9ec670f4eb906c1cb053a3f97689249388cfaadb238053","status":"promoted"}],"edges":[],"counts":{"questions":0,"evidence":2,"edges":0}},"verification":{"provenance":{"valid":true,"entries":29,"head":"c39ce1e37688e8dd8abb33e3077c960ce043ea9d153256c299c2dcfc29dd0219"},"sources":{"valid":true,"entries":49,"head":"419f6395a15cf3a3f45f7a821d163fbc48f762b5fdfa90b1221912457f84bad3"}},"counts":{"claims":48,"sources":40,"provenance":29,"contributions":21,"questions":0,"evidence_ingests":2,"voxel_edges":111},"transport":"Open every URL in this bundle with your browser or web / URL-fetch tool. Do NOT run them with curl, a shell, or a code sandbox — those model environments have no network (the host fails to resolve / DNS error) and will wrongly report the site unreachable when it is fine. Opening the link IS the call.","llm_manifest":{"version":"1","site":"https://miscsubjects.com","purpose":"Peptide evidence articles with hash-chained source ledgers, tiered claims, and a question graph. LLMs should READ bundles/URLs and WRITE back via ingest — never invent doses.","read":{"human_page":"https://miscsubjects.com/a/bpc-ara-post-surgical-nerve","bundle_json":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/topology","question_graph":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/question-graph","sources":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/sources","provenance":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/provenance","contributions":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/contributions","graph_topology":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/graph-topology?question={question}","voxels":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","health":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/health","repair":"POST https://miscsubjects.com/api/protocol/repair","list_articles":"https://miscsubjects.com/api/articles","graph_canvas":"https://miscsubjects.com/graph.html?slugs=bpc-ara-post-surgical-nerve","graph_yield":"https://miscsubjects.com/api/graph?slugs=bpc-ara-post-surgical-nerve&layer=yield","obsidian_vault":"https://miscsubjects.com/api/articles/obsidian-vault?slugs=bpc-ara-post-surgical-nerve","graph_query":"https://miscsubjects.com/api/v1/query?from=bpc-ara-post-surgical-nerve&kind=claim&where=tier=human"},"ask":{"description":"Answer only from topology; creates a question_node with gaps.","api":"POST https://miscsubjects.com/api/protocol/ask","body":{"slug":"{slug}","question":"string"},"imessage":"bpc-ara-post-surgical-nerve|your question","router_tag":"[ARTICLE_ASK]bpc-ara-post-surgical-nerve|question[/ARTICLE_ASK]","auth":"x-terminal-key header for API; iMessage/WhatsApp via miscsubjects build"},"ingest":{"description":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","api":"POST https://miscsubjects.com/api/protocol/ingest","body":{"slug":"{slug}","evidence":"paste text","question_node_id":"optional qn_..."},"imessage":"ingest bpc-ara-post-surgical-nerve|q:{node_id}|paste evidence","router_tag":"[ARTICLE_INGEST]bpc-ara-post-surgical-nerve|evidence[/ARTICLE_INGEST]","tiers":["human","preclinical","anecdotal","mechanistic","speculative"]},"claim":{"description":"Prompt-injection style POST — one claim voxel with who_claims + posted_by provenance.","api":"POST https://miscsubjects.com/api/protocol/claim","body":{"slug":"{slug}","text":"one assertion","tier":"human|preclinical|anecdotal|mechanistic|speculative","who_claims":"study author, platform, or model id","source_ids":"optional [s1]"},"imessage":"claim bpc-ara-post-surgical-nerve|tier|assertion — who claims it?","router_tag":"[ARTICLE_CLAIM]bpc-ara-post-surgical-nerve|tier|assertion[/ARTICLE_CLAIM]","slots":["what_it_is","who_claims_what","what_is_known","what_is_unknown","mechanism","limitations","disclaimer"]},"tiers":{"human":0.8,"preclinical":0.5,"anecdotal":0.3,"mechanistic":0.3,"speculative":0.1},"invariants":["Self-explaining — every API JSON has _self; every paste widget has §SELF; root index at /api/articles/system-map","Append-only — revisions preserved at ?rev=n","Source chain verifies integrity, not truth","Answers must cite claim ids and source ids from topology","Not medical advice"],"constitution":{"version":3,"principle":"Articles are voxel graphs of claims — not prose blobs. Every assertion is a claim atom with tier, weight, source_ids, and posted_by provenance.","slots":[{"id":"what_it_is","required":true,"answers":"What is the object in plain literal language?"},{"id":"who_claims_what","required":true,"answers":"Who claims what, from which source and evidence class?"},{"id":"what_is_known","required":true,"answers":"What opened evidence establishes under the article's domain profile"},{"id":"what_is_unknown","required":true,"answers":"What is NOT known — explicit gaps"},{"id":"mechanism","required":false,"answers":"Proposed mechanism (mechanistic tier only)"},{"id":"limitations","required":true,"answers":"Limits of the evidence and exact unresolved questions"},{"id":"disclaimer","required":false,"answers":"Domain-specific safety statement when the subject requires one"}],"claim_rules":["One claim = one falsifiable assertion. No compound claims.","Every claim must declare tier: human|preclinical|anecdotal|mechanistic|speculative|system.","system tier = architecture/design axioms (not biological mechanism). Use for protocol self-definition.","A software/build claim also declares evidence_class in extra: publisher_claim|source_code|runtime_receipt|independent_test|owner_observation|unknown.","Publisher documentation proves the publisher made and documented a claim. It is not independent runtime proof.","Source code proves an implementation exists. A successful receipt proves one invocation. Neither proves general reliability or field superiority.","Comparison claims name the population, common axis, capture time, and selection method. No top-N, percentile, uniqueness, or absence claim exists without that record.","Sourced claims must cite source_ids from the hash-chained ledger.","Unsourced claims must set source_status: unsourced and why_material.","posted_by is mandatory on every new claim (model id, human, or channel).","No medical advice, no doses, no 'you should take'.","Bad information is retracted (status:retracted), never deleted — retraction event stays on ledger.","Adversary challenges link via challenges[] / challenged_by[] — target may be downweighted.","Leaked secrets are scrubbed to [REDACTED:secret-leak] with scrub_events tombstone — honest audit trail."],"source_rules":["Every source is a voxel edge: type, url, exact quote, summary, found_by, accessed_at.","Sources hash-chain — prev/hash on append.","Anecdotal sources must name platform (reddit|x|youtube|imessage|user_entry).","Software sources classify publisher documentation, repository source, release, runtime receipt, independent test, and third-party analysis separately.","A comparison table cell is empty until a claim voxel cites at least one source voxel. Model prose alone is not evidence."],"writing_rules":["Literal nouns and verbs. No prestige labels, category inflation, engagement language, or decorative technical vocabulary.","Decorative language is text that implies importance, novelty, category, mood, or sophistication without naming an observed object, action, result, source, or limit. Delete it.","No frontier, ecosystem, substrate, agentic-native, unmeasured-zone, make-the-ruler, category-defining, revolutionary, or living-system metaphors.","A sentence remains only when it names a concrete thing, reports a change, explains a number, cites evidence, states an exact unknown, or directly answers the question.","Technical nouns are allowed only when literal. Define the first use by what the named code or data object stores or does.","State the observed object before naming a category for it.","Keep the evidentiary boundary beside the exact claim it limits.","Unknown means unknown. Missing evidence does not become absence."],"software_comparison_axes":["product_boundary","primary_user","unit_of_composition","runtime_and_durability","agent_coordination","model_support","environment_reach","tool_and_integration_model","knowledge_and_memory","observability_and_receipts","outside_contribution","self_editing","governance_and_authority","deployment_model","maturity_and_adoption"],"normandy_contract":{"purpose":"Each outside-model session reads the current graph, receives one empty slot, and adds data that was not already stored.","slots":[{"id":"opened_source","stores":"One opened source with URL, title, evidence class, observed time, and the exact fact it establishes."},{"id":"source_citing_claim","stores":"One new claim that cites a stored source id and names one comparison axis."},{"id":"overlap","stores":"One evidenced capability both systems have."},{"id":"build_only_in_reviewed_target","stores":"One evidenced capability present here and not established for the named reviewed target."},{"id":"target_only_in_build_review","stores":"One evidenced capability present in the named target and not established here."},{"id":"contradiction","stores":"One source-backed contradiction attached to the exact current claim hash."},{"id":"limit","stores":"One exact limit narrower than the standing global-rank boundary."},{"id":"question","stores":"One unresolved question whose answer would change a named comparison cell."},{"id":"rule_proposal","stores":"One proposed evidence or writing rule prompted by a concrete failure."},{"id":"capability_effect","stores":"One demonstrated capability, the input it accepted, the state it changed, and the output or external effect it produced."},{"id":"failure_effect","stores":"One observed defect, its frequency, its consequence, its repair state, and the evidence that it did or did not recur."},{"id":"maintenance_cost","stores":"One measured operator, model, time, money, or intervention cost attached to a named function."},{"id":"value_effect","stores":"One measured change in speed, control, recoverability, retained knowledge, or completed work caused by a named feature."}],"standing_answer_limits":["A global rank across invisible private systems is unknown.","Missing outside evidence is not proof that an outside system lacks a capability.","A successful receipt proves one run, not general reliability.","Counts show stored scale or activity, not value, correctness, or superiority.","Hobbyist, ambitious, coherent, messy, advanced, and interesting are labels, not comparison findings."],"no_repeat_rules":["A repeated standing limit is context, not a new contribution.","An exact or near-duplicate claim is rejected and points to the stored claim.","A duplicate source does not complete an assignment.","A response completes only after at least one new graph object lands.","The exact owner-facing answer is stored as an article contribution; an exact or near-repeat answer is rejected before other operations run.","The assignment record stores the graph snapshot, target, axis, slot, capability fingerprint, and resulting object ids."],"assignment":"GET /api/normandy?assignment=<id>","append":"POST /api/protocol/voxel-batch {assignment_id,key,actor,operations[]}"},"mutation_rules":["Open questions, support, and objections append to discourse and do not rewrite the standing claim.","Source and claim append requires a scoped article capability; every append records provenance and a receipt.","Existing text edits use the current voxel hash. A stale hash writes nothing.","Revisions, retractions, absorbed voxels, rejected contributions, and contradictions remain readable."],"ontology_rules":["Peptide articles (bpc-157, tb-500) are tree roots.","Condition articles (bpc-157-glp1-gut-damage) branch from peptides.","Stack articles (wolverine-stack-glp1) compose peptides — never duplicate peptide mechanism prose.","If an article has no parent embeds and is not a root peptide → sprawl candidate.","Misstep = duplicate scope with another slug; merge or reparent via embeds."],"post_protocol":{"claim":"POST /api/protocol/claim","source":"POST /api/protocol/sources","ingest":"POST /api/protocol/ingest","webhook":"POST /api/articles/<slug>/webhook {kind:claim|source}","imessage_claim":"claim {slug}|{tier}|your assertion — who claims it, source?","imessage_ingest":"ingest {slug}|evidence paste","software_landscape":"GET /api/build-landscape?next=1&lane=field|build|opposition|synthesis","queue_population":"POST /api/build-landscape {action:queue_targets, cohort, query, sort, captured_at, source_url, targets[]}"}},"this_article":{"slug":"bpc-ara-post-surgical-nerve","url":"https://miscsubjects.com/a/bpc-ara-post-surgical-nerve","bundle_url":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle?format=markdown"},"voxel_procedure":{"what":"Every article has a human side (/a/bpc-ara-post-surgical-nerve) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"bpc-ara-post-surgical-nerve\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"bpc-ara-post-surgical-nerve\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"bpc-ara-post-surgical-nerve\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"bpc-ara-post-surgical-nerve\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"bpc-ara-post-surgical-nerve\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"bpc-ara-post-surgical-nerve\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/bpc-ara-post-surgical-nerve/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/bpc-ara-post-surgical-nerve#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."}},"api_urls":{"bundle":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/topology","voxels":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","question_graph":"https://miscsubjects.com/api/articles/bpc-ara-post-surgical-nerve/question-graph","ask":"https://miscsubjects.com/api/protocol/ask","ingest":"https://miscsubjects.com/api/protocol/ingest","claim":"https://miscsubjects.com/api/protocol/claim","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown"}}